{
    "2018-10-30": [
        [
            {
                "time": "2018-10-25",
                "original_text": "Amgen Earnings, Revenue beat in Q3",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Earnings",
                        "Revenue",
                        "beat",
                        "Q3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery?",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Fragile",
                        "Rebound",
                        "Sector",
                        "Recovery"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-29",
                "original_text": "Pfizer Missed Analysts’ Third-Quarter Revenue Estimates",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Missed",
                        "Analysts'",
                        "Third-Quarter",
                        "Revenue",
                        "Estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Beats",
                        "Q3",
                        "Earnings",
                        "Meets",
                        "Sales",
                        "Narrows",
                        "View"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "HCA Earnings, Revenue beat in Q3",
                "features": {
                    "keywords": [
                        "HCA",
                        "Earnings",
                        "Revenue",
                        "beat",
                        "Q3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "2 “Forever” Stocks to Grab on This Pullback (paying up to 7.7%)",
                "features": {
                    "keywords": [
                        "Forever",
                        "Stocks",
                        "Grab",
                        "Pullback",
                        "paying",
                        "7.7%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Pfizer Earnings beat, Revenue misses In Q3",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Earnings",
                        "beat",
                        "Revenue",
                        "misses",
                        "Q3"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-03",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Johnson & Johnson",
                        "UnitedHealth",
                        "AT&T",
                        "Intel"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "telecommunications",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}